![Stephanie Kenney](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profilo
Stephanie Kenney is currently Chief Corporate Affairs Officer at Atrium Therapeutics, Inc. Formerly, Ms. Kenney was Vice President-Global Corporate Affairs at Hansa Biopharma AB from 2022 to 2025.
Ms. Kenney completed undergraduate studies at Mansfield University of Pennsylvania.
Posizioni attive di Stephanie Kenney
| Società | Posizione | Inizio |
|---|
Precedenti posizioni note di Stephanie Kenney
| Società | Posizione | Fine |
|---|---|---|
| HANSA BIOPHARMA AB | Public Communications Contact | 31/08/2025 |
Formazione di Stephanie Kenney
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
25
Relazioni di 1° grado
2
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Mansfield University of Pennsylvania
 Mansfield University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hansa Biopharma AB
 Hansa Biopharma AB Pharmaceuticals: MajorHealth Technology Develops therapies and medicines for the treatment of immunomodulatory | Health Technology |
